Metabolic activity assessment of cardiac angiosarcoma by 18FDG PET-CT
Nuclear Medicine Review · 2012
DOI: 10.5603/nmr-18736 ↗Kurz gefasst
Fallbericht in der Zeitschrift Nuclear Medicine Review, 2012. Verfasst von Marek Bilski und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology and Isotope Therapy, Military Institute of Medicine, 128 Szaserow St., 04–141 Warsaw, Poland. mbilski@wim.mil.pl. Hauptthemen laut MEDLINE: Fluorodeoxyglucose F18, Multimodal Imaging, Positron-Emission Tomography, Tomography, X-Ray Computed.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology and Isotope Therapy, Military Institute of Medicine, 128 Szaserow St., 04–141 Warsaw, Poland. mbilski@wim.mil.pl
Zitieren
APA
Bilski, M., Kamiński, G., & Dziuk, M. (2012). Metabolic activity assessment of cardiac angiosarcoma by 18FDG PET-CT. Nuclear Medicine Review. https://doi.org/10.5603/nmr-18736
Vancouver
Bilski M, Kamiński G, Dziuk M. Metabolic activity assessment of cardiac angiosarcoma by 18FDG PET-CT. Nuclear Medicine Review. 2012. doi:10.5603/nmr-18736
BibTeX
@article{Bilski2012,
author = {Bilski, Marek and Kamiński, Grzegorz and Dziuk, Mirosław},
title = {Metabolic activity assessment of cardiac angiosarcoma by 18FDG PET-CT},
journal = {Nuclear Medicine Review},
year = {2012},
doi = {10.5603/nmr-18736}
}
EUVIMED